Skip to main content
. Author manuscript; available in PMC: 2013 Aug 30.
Published in final edited form as: Neuroscience. 2012 Jun 1;218:243–256. doi: 10.1016/j.neuroscience.2012.05.052

Figure 4.

Figure 4

Effects of bilateral MFB 6-OHDA and subsequent chronic L-DOPA (12 mg/kg, + benserazide, 15 mg/kg, sc; LD) on motor and anxiety-like behaviors in the locomotor chambers. Bars denote the effect of group on (A) movement number, (B) overall vertical movement number, (C) center entries, and (D) center vertical movements. Group effects were determined by one-way ANOVAs and Fisher LSD post hocs were used to analyze group differences (*p<0.05 vs. Sham-VEH).